Core Scientific, Inc. current report, 12 February 2021

Core Scientific, Inc. — Filing Summary

Filing and reporting period: The provided Form 8-K is filed by Power & Digital Infrastructure Acquisition Corp. (XPDI), not Core Scientific, Inc. The report covers events occurring on February 12, 2021, with the filing signed February 19, 2021.

Business Context

XPDI reported the closing of its initial public offering and related private placement. At this stage, it was a special purpose acquisition company and had not reported operating results for Core Scientific or a completed business combination in the provided text.

Key Financial and Capital Markets Metrics

  • IPO: 34.5 million units issued at $10.00 per unit, including the underwriters’ full purchase of 4.5 million additional units.
  • Private placement: 6,266,667 warrants sold at $1.50 per warrant to XPDI Sponsor LLC and certain BlackRock-managed funds and accounts.
  • Offering proceeds: $345.0 million placed in a trust account, consisting of IPO proceeds and certain private-placement proceeds.
  • Each unit included one share of Class A common stock and one-fourth of one redeemable warrant. Each whole warrant is exercisable at $11.50 per share.
  • The filing text does not provide clear values for revenue, net income, operating cash flow, margins, debt, or other operating metrics.

Material Changes and Unusual Items

The material event was completion of XPDI’s IPO and private placement. The company also included an audited balance sheet as of February 12, 2021 as Exhibit 99.1, reflecting receipt of the offering proceeds.

Guidance, Outlook, Risks, and Contingencies

  • Funds in the trust account generally cannot be released until the earlier of completion of an initial business combination or redemption of all public Class A shares if no combination is completed within 24 months after the IPO closing.
  • Permitted withdrawals include amounts needed for franchise and income taxes and amounts associated with redemptions resulting from specified amendments to the company’s charter.
  • The filing does not provide operating guidance, projections, management commentary regarding Core Scientific, or a detailed risk discussion.

Investor Verification Items

  • Confirm that the filing belongs to Power & Digital Infrastructure Acquisition Corp. rather than Core Scientific, Inc.
  • Review Exhibit 99.1 for the audited balance sheet and the precise trust-account, cash, and liability balances.
  • Verify the terms and completion status of XPDI’s subsequent business combination, including any shareholder redemptions or financing changes.
  • Confirm the applicable 24-month deadline and any amendments affecting the trust account or redemption rights.